Clinical Trials Directory

Trials / Completed

CompletedNCT05663333

Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)

Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
Centre Hospitalier William Morey - Chalon sur Saône · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Giant cell arteritis (GCA) is a type of large vessel granulomatous vasculitis responsible for the inflammation of the aorta and the branches of the external carotid, notably temporal arteries. The diagnosis of GCA relies upon the identification of vasculitis following histopathological analysis of temporal artery biopsy (TAB) showing mononuclear cells infiltration, fragmentation of the internal elastic lamina as well as significant intimal hyperplasia. Apart from its lack of sensitivity, one of the weaknesses of TAB is the delay in obtaining the result due to the time required to prepare the sample for histological analysis. Pursuing the idea to improve TAB performances, our group recently demonstrated the use of full-field optical coherence tomography (FF-OCT) to visualize structural changes associated with the inflammatory processes of GCA. The present work suggests a further use of dynamic FF-OCT on TAB for a direct visualization of the mononuclear cells infiltration to ensure rapid on-site diagnosis of GCA.

Conditions

Interventions

TypeNameDescription
OTHERDynamic full-field optical coherence tomography analysis of temporal artery biopsyDynamic full-field optical coherence tomography analysis of temporal artery biopsy in the dermatology department before conventional histopathological analysis

Timeline

Start date
2023-01-26
Primary completion
2024-06-30
Completion
2024-07-31
First posted
2022-12-23
Last updated
2024-08-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05663333. Inclusion in this directory is not an endorsement.